Prof.  

Herve Bachelez

, France


Presentations

Safety of Risankizumab in Patients With Moderate-to-Severe Psoriasis: Analysis of Pooled Clinical Trial Data 09 October 2019 00:00 - 00:00

Abstracts

Safety of Risankizumab in Patients With Moderate-to-Severe Psoriasis: Analysis of Pooled Clinical Trial Data Psoriasis More